Quanterix Corporation (QTRX): Price and Financial Metrics


Quanterix Corporation (QTRX)

Today's Latest Price: $27.50 USD

0.59 (2.19%)

Updated Jul 9 4:00pm

Add QTRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

QTRX Stock Summary

  • QTRX's went public 2.59 years ago, making it older than merely 7.68% of listed US stocks we're tracking.
  • QTRX's price/sales ratio is 12.67; that's higher than the P/S ratio of 89.45% of US stocks.
  • With a year-over-year growth in debt of 296.87%, Quanterix Corp's debt growth rate surpasses 94.66% of about US stocks.
  • Stocks that are quantitatively similar to QTRX, based on their financial statements, market capitalization, and price volatility, are ECOR, IGC, LC, FLDM, and TUFN.
  • Visit QTRX's SEC page to see the company's official filings. To visit the company's web site, go to www.quanterix.com.
QTRX Daily Price Range
QTRX 52-Week Price Range

QTRX Stock Price Chart Technical Analysis Charts


QTRX Price/Volume Stats

Current price $27.50 52-week high $33.67
Prev. close $26.91 52-week low $10.90
Day low $26.51 Volume 115,338
Day high $27.92 Avg. volume 166,958
50-day MA $26.51 Dividend yield N/A
200-day MA $23.73 Market Cap 778.55M

Quanterix Corporation (QTRX) Company Bio


Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.


QTRX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

QTRX Latest Social Stream


Loading social stream, please wait...

View Full QTRX Social Stream

Latest QTRX News From Around the Web

Below are the latest news stories about Quanterix Corp that investors may wish to consider to help them evaluate QTRX as an investment opportunity.

Is Quanterix Corporation (QTRX) A Good Stock To Buy?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

Yahoo | July 6, 2020

Quanterix Corporation CEO to Present at MassBio: Possible Talk Series

Chairman and Chief Executive Officer Kevin Hrusovsky will participate in the MassBio: Possible Talk series on June 26.

Yahoo | June 26, 2020

Quanterix to Host Virtual Annual Meeting of Stockholders

Quanterix will hold its 2020 Annual Meeting of Stockholders virtually on June 25, 2020, at 10:00 a.m. ET.

Yahoo | June 11, 2020

Quanterix Expands Menu of Ultra-Sensitive Neurology Assays with Simoa® P-Tau181 V2 Kit for Improved Detection and Study of Alzheimer’s Disease

Quanterix announces it will expand its robust menu of ready-to-use Simoa® kits to include tau phosphorylated at threonine 181 (p-tau181).

Yahoo | May 29, 2020

Quanterix’ Simoa Technology Sets New Standard in Protein Detection

Quanterix announced that it has successfully applied its Simoa® technology to achieve a 100x sensitivity improvement.

Yahoo | May 13, 2020

Read More 'QTRX' Stories Here

QTRX Price Returns

1-mo 3.97%
3-mo N/A
6-mo 26.73%
1-year -12.86%
3-year N/A
5-year N/A
YTD 16.38%
2019 29.06%
2018 -14.72%
2017 N/A
2016 N/A
2015 N/A

Continue Researching QTRX

Want to see what other sources are saying about Quanterix Corp's financials and stock price? Try the links below:

Quanterix Corp (QTRX) Stock Price | Nasdaq
Quanterix Corp (QTRX) Stock Quote, History and News - Yahoo Finance
Quanterix Corp (QTRX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.1004 seconds.